These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6745538)
41. 3,3',4,4'-tetrachloroazobenzene absorption, disposition, and metabolism in male Fischer 344 rats. Pillai UA; Ziegler TL; Wang DX; Kattnig MJ; McClure T; Liebler DC; Mayersohn M; Sipes IG Drug Metab Dispos; 1996 Feb; 24(2):238-44. PubMed ID: 8742237 [TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105. Mukai H; Sugimoto T; Ago M; Morino A Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039 [TBL] [Abstract][Full Text] [Related]
43. Disposition of decabromobiphenyl ether in rats dosed intravenously or by feeding. el Dareer SM; Kalin JR; Tillery KF; Hill DL J Toxicol Environ Health; 1987; 22(4):405-15. PubMed ID: 3694703 [TBL] [Abstract][Full Text] [Related]
44. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats. Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645 [TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound. Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556 [TBL] [Abstract][Full Text] [Related]
46. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957 [TBL] [Abstract][Full Text] [Related]
47. The metabolic disposition of 14C-labelled carmoisine in the rat after oral and intravenous administration. Galli CL; Marinovich M; Costa LG Food Chem Toxicol; 1982 Aug; 20(4):351-6. PubMed ID: 6890016 [TBL] [Abstract][Full Text] [Related]
48. Disposition of 1,2,3,7,8-pentachlorodibenzofuran in the rat. Brewster DW; Birnbaum LS Toxicol Appl Pharmacol; 1988 Sep; 95(3):490-8. PubMed ID: 3188012 [TBL] [Abstract][Full Text] [Related]
49. Disposition and metabolism of aniline in Fischer 344 rats and C57BL/6 X C3H F1 mice. McCarthy DJ; Waud WR; Struck RF; Hill DL Cancer Res; 1985 Jan; 45(1):174-80. PubMed ID: 2578091 [TBL] [Abstract][Full Text] [Related]
50. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
51. Disposition and metabolism of [14C]sparfloxacin in the rat. Matsunaga Y; Miyazaki H; Oh-e Y; Nambu K; Furukawa H; Yoshida K; Hashimoto M Arzneimittelforschung; 1991 Jul; 41(7):747-59. PubMed ID: 1663354 [TBL] [Abstract][Full Text] [Related]
52. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats. Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446 [TBL] [Abstract][Full Text] [Related]
53. [Absorption, distribution, excretion and metabolism of [14C] T-3761 in rats and mice]. Hayakawa H; Hayashi K; Sakai H; Ishikura H; Takagi H; Nakajima Y; Sogame Y Jpn J Antibiot; 1995 May; 48(5):671-85. PubMed ID: 7637202 [TBL] [Abstract][Full Text] [Related]
54. Metabolism of carprofen, a nonsteroid anti-inflammatory agent, in rats, dogs, and humans. Rubio F; Seawall S; Pocelinko R; DeBarbieri B; Benz W; Berger L; Morgan L; Pao J; Williams TH; Koechlin B J Pharm Sci; 1980 Nov; 69(11):1245-53. PubMed ID: 7452450 [TBL] [Abstract][Full Text] [Related]
55. Metabolism, disposition and excretion of [14C]melamine in male Fischer 344 rats. Mast RW; Jeffcoat AR; Sadler BM; Kraska RC; Friedman MA Food Chem Toxicol; 1983 Dec; 21(6):807-10. PubMed ID: 6686586 [TBL] [Abstract][Full Text] [Related]
56. Metabolism and disposition of the flame retardant plasticizer, tri-p-cresyl phosphate, in the rat. Kurebayashi H; Tanaka A; Yamaha T Toxicol Appl Pharmacol; 1985 Mar; 77(3):395-404. PubMed ID: 3919466 [TBL] [Abstract][Full Text] [Related]
57. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys. Emary WB; Toren PC; Mathews B; Huh K Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285 [TBL] [Abstract][Full Text] [Related]
58. Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism. Maurer G; Schreier E; Delaborde S; Nufer R; Shukla AP Eur J Drug Metab Pharmacokinet; 1983; 8(1):51-62. PubMed ID: 6861794 [TBL] [Abstract][Full Text] [Related]
59. The absorption, tissue distribution and excretion of di-n-octyltin dichloride in rats. Penninks AH; Hilgers L; Seinen W Toxicology; 1987 Apr; 44(1):107-20. PubMed ID: 3564046 [TBL] [Abstract][Full Text] [Related]
60. Metabolism and disposition of 2-methoxy-4-nitroaniline in male and female Harlan Sprague Dawley rats and B6C3F1/N mice. Mathews JM; Zhan Q; Etheridge AS; Patel PR; Black SR; Banks TT; Fennell TR; Snyder RW; Burgess JP; Warren SD; Surh I; Waidyanatha S Xenobiotica; 2012 Dec; 42(12):1213-24. PubMed ID: 22725680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]